Israeli Jews

Matinas BioPharma to Webcast Conference Call Discussing Third Quarter 2020 Financial and Operational Results on November 6, 2020

Retrieved on: 
Friday, October 23, 2020

ET to discuss operational and financial results for the third quarter ended September 30, 2020.

Key Points: 
  • ET to discuss operational and financial results for the third quarter ended September 30, 2020.
  • The live webcast will be accessible on the Investors section of Matinas website, www.matinasbiopharma.com , and will be archived for 90 days.
  • Matinas BioPharma is a clinical-stage biopharmaceutical company focused on developing next generation therapeutics to advance standards of care for patients in areas of significant unmet medical need.
  • Matinas BioPharmas product candidates are all in a development stage and are not available for sale or use.

The Tel-Aviv Stock Exchange Launches a Specialized Innovative Digital Service - Exercise of Employee Stock Options in Click

Retrieved on: 
Wednesday, October 14, 2020

TEL AVIV, Israel, Oct. 14, 2020 /PRNewswire/ -- The Tel-Aviv Stock Exchange (TASE: TASE) announces the launch of a new specialized service that allows public companies with employee stock option plans to digitally exercise employee stock options.

Key Points: 
  • TEL AVIV, Israel, Oct. 14, 2020 /PRNewswire/ -- The Tel-Aviv Stock Exchange (TASE: TASE) announces the launch of a new specialized service that allows public companies with employee stock option plans to digitally exercise employee stock options.
  • The service will be provided by TASE's Nominee Company and is designated for companies that are listed on TASE and registered with the Nominee Company.
  • This innovative service offers listed companies a secure digital, easy and quick way to exercise employee stock options without drafting and printing documents, signing them manually and having them delivered by courier.
  • The Tel-Aviv Stock Exchange Nominee Company Ltd. was established in January 2018 as part of the TASE Group.

LIGC announces $3M USD Series A funding from Hubei Forbon Technology Co. Ltd

Retrieved on: 
Tuesday, September 15, 2020

TEL AVIV, Israel, Sept. 15, 2020 /PRNewswire-PRWeb/ -- Today, Israeli startup LIGC announced a $3M USD Series A round from public listed Wuhan-based Hubei Forbon Technology Co. Ltd (300387.SZ).

Key Points: 
  • TEL AVIV, Israel, Sept. 15, 2020 /PRNewswire-PRWeb/ -- Today, Israeli startup LIGC announced a $3M USD Series A round from public listed Wuhan-based Hubei Forbon Technology Co. Ltd (300387.SZ).
  • The funding will be used to scale and manufacture LIGC's Laser-Induced Graphene filters (LIG).
  • The technology was developed by Houston's Rice University in partnership with Ben-Gurion University (BGU) of the Negev in Israel and was licensed from BGN technologies, the technology transfer company of BGU.
  • In addition, LIGC active filters require lower maintenance than other filters and are safe to the operator during maintenance and replacement.

Mattel Chairman and CEO Ynon Kreiz to Participate in Virtual Goldman Sachs Communacopia Conference

Retrieved on: 
Monday, September 14, 2020

Mattel, Inc. (NASDAQ: MAT) today announced that Chairman and Chief Executive Officer Ynon Kreiz will participate in a fireside chat at the virtual Goldman Sachs Communacopia Conference on Tuesday September 15, 2020 at 2:05 p.m. Eastern time.

Key Points: 
  • Mattel, Inc. (NASDAQ: MAT) today announced that Chairman and Chief Executive Officer Ynon Kreiz will participate in a fireside chat at the virtual Goldman Sachs Communacopia Conference on Tuesday September 15, 2020 at 2:05 p.m. Eastern time.
  • The webcast will be available on Mattels Investor Relations website, https://mattel.gcs-web.com/ .
  • An archive of the webcast will be available on the Companys website shortly after the completion of the live webcast.
  • Mattel is a leading global toy company and owner of one of the strongest catalogs of childrens and family entertainment franchises in the world.

UAE's Mohamed bin Zayed University of Artificial Intelligence and Israel's Weizmann Institute of Science sign first of its kind MoU to collaborate on AI research

Retrieved on: 
Sunday, September 13, 2020

Based in Abu Dhabi, the University offers MSc and PhD programs in computer vision, machine learning, and natural language processing.

Key Points: 
  • Based in Abu Dhabi, the University offers MSc and PhD programs in computer vision, machine learning, and natural language processing.
  • The Weizmann Institute of Science is one of the world's top-ranking multidisciplinary research institutions and offers masters' and doctoral-level degrees across five faculties.
  • Institute scientists are advancing research on the human brain, artificial intelligence, computer science and encryption, astrophysics and particle physics.
  • Therefore, I welcome the opportunity to collaborate with such a renowned establishment as the Weizmann Institute of Science.

UAE's Mohamed bin Zayed University of Artificial Intelligence and Israel's Weizmann Institute of Science sign first of its kind MoU to collaborate on AI research

Retrieved on: 
Sunday, September 13, 2020

Based in Abu Dhabi, the University offers MSc and PhD programs in computer vision, machine learning, and natural language processing.

Key Points: 
  • Based in Abu Dhabi, the University offers MSc and PhD programs in computer vision, machine learning, and natural language processing.
  • The Weizmann Institute of Science is one of the world's top-ranking multidisciplinary research institutions and offers masters' and doctoral-level degrees across five faculties.
  • Institute scientists are advancing research on the human brain, artificial intelligence, computer science and encryption, astrophysics and particle physics.
  • Therefore, I welcome the opportunity to collaborate with such a renowned establishment as the Weizmann Institute of Science.

Ovid Therapeutics to Present at the 2020 Cantor Fitzgerald Virtual Global Healthcare Conference

Retrieved on: 
Friday, September 11, 2020

NEW YORK, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc.(NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced that management will present at the 2020 Cantor Fitzgerald Virtual Global Healthcare Conference on Thursday, September 17, 2020, at 2:00 p.m.

Key Points: 
  • NEW YORK, Sept. 11, 2020 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc.(NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced that management will present at the 2020 Cantor Fitzgerald Virtual Global Healthcare Conference on Thursday, September 17, 2020, at 2:00 p.m.
  • A live audio webcast of the discussion can be accessed through the Events & Presentations section of the Company's website at investors.ovidrx.com .
  • Ovid Therapeutics Inc. is a New York-based biopharmaceutical company using its BoldMedicineapproach to develop medicines that transform the lives of patients with rare neurological disorders.
  • Ovid is also developing OV935 (soticlestat) in collaboration with Takeda Pharmaceutical Company Limited for the potential treatment of rare developmental and epileptic encephalopathies (DEE).

Otonomy to Participate in Four Upcoming Investor Conferences

Retrieved on: 
Wednesday, September 2, 2020

SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc.(Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that management is scheduled to participate in four upcoming virtual investor conferences.

Key Points: 
  • SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc.(Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that management is scheduled to participate in four upcoming virtual investor conferences.
  • Citis 15th Annual BioPharma Virtual Conference on September 9-10, 2020: 1 on 1 investor meetings.
  • H.C. Wainwright 22nd Annual Global Investment Conference: presentation on September 14, 2020 at 12 p.m.
  • Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology.

Mattel Mourns the Passing of Former Chairman and CEO Bryan G. Stockton

Retrieved on: 
Sunday, August 2, 2020

Mattel, Inc. (NASDAQ: MAT) mourns the tragic passing of Bryan G. Stockton, former Chairman and CEO of Mattel.

Key Points: 
  • Mattel, Inc. (NASDAQ: MAT) mourns the tragic passing of Bryan G. Stockton, former Chairman and CEO of Mattel.
  • Ynon Kreiz, Chairman and CEO of Mattel said, We are saddened by the news of Bryans sudden passing.
  • Bryan was a beloved leader at Mattel whose many contributions to the toy industry will live on for years to come.
  • Stockton spent 15 years at Mattel, including serving as Chief Executive Officer from 2012 to 2015 and Chairman from 2013 to 2015.

Diana S. Ferguson Appointed to Mattel Board of Directors

Retrieved on: 
Wednesday, July 22, 2020

Mattel, Inc. (NASDAQ: MAT) announced today that Diana S. Ferguson, Chief Financial Officer of Cleveland Avenue LLC, has been appointed to the Companys Board of Directors effective July 21, 2020.

Key Points: 
  • Mattel, Inc. (NASDAQ: MAT) announced today that Diana S. Ferguson, Chief Financial Officer of Cleveland Avenue LLC, has been appointed to the Companys Board of Directors effective July 21, 2020.
  • Diana is a highly experienced executive who brings a proven track record of corporate financial management and strategic planning to our Board, said Ynon Kreiz, Chairman and CEO of Mattel.
  • I look forward to working with Ynon and the rest of the Board on the transformation journey that is well under way, said Ferguson.
  • Ferguson is a member of the Board of Directors of Frontier Communications, where she serves on the Nominating and Governance Committee and chairs the Compensation Committee.